Cargando…
A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction
Erectile dysfunction (ED) affects up to 50% of men between the ages of 40 and 70. Treatment with PDE-5 inhibitors is effective in the majority of men with ED. However, PDE-5 inhibitors are not effective when levels of nitric oxide (NO), the principle mediator of erection, are low. The pharmacologic...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997760/ https://www.ncbi.nlm.nih.gov/pubmed/21152267 http://dx.doi.org/10.1155/2010/730861 |
_version_ | 1782193322087940096 |
---|---|
author | Lasker, George F. Maley, Jason H. Kadowitz, Philip J. |
author_facet | Lasker, George F. Maley, Jason H. Kadowitz, Philip J. |
author_sort | Lasker, George F. |
collection | PubMed |
description | Erectile dysfunction (ED) affects up to 50% of men between the ages of 40 and 70. Treatment with PDE-5 inhibitors is effective in the majority of men with ED. However, PDE-5 inhibitors are not effective when levels of nitric oxide (NO), the principle mediator of erection, are low. The pharmacologic actions of three new potential treatments for ED are discussed in this paper: (1) sGC stimulators/activators, (2) Rho-kinase inhibitors, and (3) sodium nitrite. |
format | Text |
id | pubmed-2997760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-29977602010-12-06 A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction Lasker, George F. Maley, Jason H. Kadowitz, Philip J. Adv Pharmacol Sci Review Article Erectile dysfunction (ED) affects up to 50% of men between the ages of 40 and 70. Treatment with PDE-5 inhibitors is effective in the majority of men with ED. However, PDE-5 inhibitors are not effective when levels of nitric oxide (NO), the principle mediator of erection, are low. The pharmacologic actions of three new potential treatments for ED are discussed in this paper: (1) sGC stimulators/activators, (2) Rho-kinase inhibitors, and (3) sodium nitrite. Hindawi Publishing Corporation 2010 2010-07-18 /pmc/articles/PMC2997760/ /pubmed/21152267 http://dx.doi.org/10.1155/2010/730861 Text en Copyright © 2010 George F. Lasker et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Lasker, George F. Maley, Jason H. Kadowitz, Philip J. A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction |
title | A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction |
title_full | A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction |
title_fullStr | A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction |
title_full_unstemmed | A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction |
title_short | A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction |
title_sort | review of the pathophysiology and novel treatments for erectile dysfunction |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997760/ https://www.ncbi.nlm.nih.gov/pubmed/21152267 http://dx.doi.org/10.1155/2010/730861 |
work_keys_str_mv | AT laskergeorgef areviewofthepathophysiologyandnoveltreatmentsforerectiledysfunction AT maleyjasonh areviewofthepathophysiologyandnoveltreatmentsforerectiledysfunction AT kadowitzphilipj areviewofthepathophysiologyandnoveltreatmentsforerectiledysfunction AT laskergeorgef reviewofthepathophysiologyandnoveltreatmentsforerectiledysfunction AT maleyjasonh reviewofthepathophysiologyandnoveltreatmentsforerectiledysfunction AT kadowitzphilipj reviewofthepathophysiologyandnoveltreatmentsforerectiledysfunction |